A patient undergoing major bowel resection receives opioid analgesics postoperatively and develops delayed recovery of gastrointestinal motility due to opioid-mediated inhibition of the gut. Which of the following peripherally acting μ-opioid receptor antagonist (PAMORA) is used to accelerate gastrointestinal recovery in this setting?